Literature DB >> 417887

Enhancement and inhibition of immunological mechanisms by immunosuppressive agents. I. Dose effect on priming and generation of memory to a bacterial antigen.

A J Macario, E Conway de Macario.   

Abstract

A new experimental system is described which allows the study of the effect of immunosuppressors upon the priming and generation of memory to an antigen from Escherichia coli. A single dose of bacterial beta-D-galactosidase without adjuvant injected into C57B1/6J mice primes and elicits memory but not antibodies. Thus by administering immunosuppressors near the priming injection, one can examine whether primary antibody formation is enhanced and whether priming generation of memory is enhanced or inhibited. We found that X-rays, cyclophosphamide and oxisuran (2-[(methylsulfinyl)acetyl]pyridine) either enhance or inhibit the elicitation of memory, depending on dosage, although they do not alter primary antibody unresponsiveness. The data show two main features: (a) immunosuppressors can enhance immunization; and (b) generation of memory can be improved without increasing antibody levels. The former finding draws attention to the role that immunosuppressors might play in the breaching of tolerance to self-antigens which share determinants with microbes, while the latter observation shows that antibody synthesis and elicitation of memory can follow independent pathways.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 417887      PMCID: PMC1541225     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

Review 1.  Ionizing radiation and the immune response.

Authors:  R E Anderson; N L Warner
Journal:  Adv Immunol       Date:  1976       Impact factor: 3.543

2.  Treatment of refractory thrombocytopenic purpura with cyclophosphamine.

Authors:  M Verlin; R K Laros; J A Penner
Journal:  Am J Hematol       Date:  1976       Impact factor: 10.047

3.  Radiosensitivity of T and B lymphocytes. IV. Effect of whole body irradiation upon various lymphoid tissues and numbers of recirculating lymphocytes.

Authors:  R E Anderson; G B Olson; J R Autry; J L Howarth; G M Troup; P H Bartels
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

4.  Selective thymus-derived cell enrichment in the rat spleen as a result of immunodepression by urethan.

Authors:  A T Di Marco; C Franceschi; G Prodi
Journal:  Cancer Res       Date:  1972-07       Impact factor: 12.701

5.  An immunoenzymatic system to study in vitro immune responses. Synthesis of antibodies directed toward different -D-galactosidase determinants in lymph node fragment cultures.

Authors:  A J Macario; E Conway de Macario; F Celada
Journal:  Immunology       Date:  1973-02       Impact factor: 7.397

6.  Regulation of the antibody response to type 3 pneumococcal polysaccharide. II. Mode of action of thymic-derived suppressor cells.

Authors:  P J Baker; P W Stashak; D F Amsbaugh; B Prescott
Journal:  J Immunol       Date:  1974-01       Impact factor: 5.422

7.  Acute hemolytic anemia associated with administration of alkylating agents: report of two cases due to cyclophosphamide and review of the literature.

Authors:  H M Yonet; E M Vigliano; H I Horowitz
Journal:  Am J Med Sci       Date:  1967-07       Impact factor: 2.378

8.  X-radiation and alkylating agents as possible "trigger" mechanisms in the autoimmune complications of malignant lymphophroliferative disease.

Authors:  F B Lewis; R S Schwartz; W Dameshek
Journal:  Clin Exp Immunol       Date:  1966-01       Impact factor: 4.330

9.  Hapten-specific IgE antibody responses in mice. VII. Conversion of IgE "non-responder" strains to IgE "responders" by elimination of suppressor T cell activity.

Authors:  N Chiorazzi; D A Fox; D H Katz
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

10.  Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes.

Authors:  M Röllinghoff; A Starzinski-Powitz; K Pfizenmaier; H Wagner
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.